BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20220313T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20221106T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230815T130000
DTEND;TZID=America/Halifax:20230815T143000
DTSTAMP:20260407T014656
CREATED:20230712T154440Z
LAST-MODIFIED:20241024T182918Z
UID:10000655-1692104400-1692109800@staging.digitalinsights.supremeclients.com
SUMMARY:Part I: Single-cell RNA sequencing data analysis using QIAGEN CLC Genomics Workbench
DESCRIPTION:This two-part series will walk you through single-cell RNA sequencing (scRNA-seq) analysis starting with a matrix file or FASTQ files and ending with a deep understanding of key pathways\, regulators and cell type signatures within your data. \nThis session is for part I of this training. In this session\, you'll learn to use QIAGEN CLC Genomics Workbench to perform secondary analysis on your scRNA-seq data. Specifically\, you will learn how to:\n• Import your raw FASTQ or processed cell-matrix files\n• Use pre-configured but customizable pipelines/workflows for scRNA-seq data\n• Generate high-resolution visuals and other files from your analysis for publications and biopharmaceutical discoveries. These include: \no UMAP\, t-SNE plots\no Differential expression table for clusters\, cell types\, or a combination of both\no Heat map\no Dot plots\no Violin plots \nPart II of this training takes place on Wednesday\, Aug. 16. It focuses on interpreting scRNA-seq data using QIAGEN Ingenuity Pathway Analysis (IPA) to understand key pathways\, regulators and cell type signatures within your data. Here you can register for Part II: https://qiagen.zoom.us/webinar/register/4716889476421/WN_IA23wGOhQMa_dSc6QJiTkw
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/part-i-single-cell-rna-sequencing-data-analysis-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1108_8_QDI_CLC_Challenger_Or54963_16x9_56810_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230810T130000
DTEND;TZID=America/Halifax:20230810T143000
DTSTAMP:20260407T014656
CREATED:20230712T153833Z
LAST-MODIFIED:20241024T182917Z
UID:10000654-1691672400-1691677800@staging.digitalinsights.supremeclients.com
SUMMARY:Interpreting genetic risk loci from GWAS in the context of key genes and pathways using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:Genome-wide association studies (GWAS) provide insights into the genetic architecture of disease by identifying susceptibility loci for the disease within a population. If you'd like to identify disease genes and novel biological pathways that underlay the disease pathogenesis to identify novel drug targets\, QIAGEN Ingenuity Pathway Analysis (IPA) helps you characterize and validate risk loci within a biological context. In this training\, you'll discover how to perform a core analysis for a list of risk loci to study their association with different pathways and regulatory networks. \nYou'll learn how to:\n• Upload and perform a core analysis on a list of GWAS risk loci\n• Investigate pathways and regulatory networks to understand biological mechanisms\n• Compare enrichment between risk loci analysis to identify biological similarities and difference\n• Identify commonalities and differences between risk loci list\n• Generate a custom network and contextualize it using public data\n• Export high-resolution images and comprehensive tabular results in preferred formats
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/interpreting-genetic-risk-loci-from-gwas-in-the-context-of-key-genes-and-pathways-using-qiagen-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9343_QDI_IPA_Gi615617548_V2_16x9_Medium-720px_49299.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230808T130000
DTEND;TZID=UTC:20230808T143000
DTSTAMP:20260407T014656
CREATED:20230712T153022Z
LAST-MODIFIED:20241024T182917Z
UID:10000653-1691499600-1691505000@staging.digitalinsights.supremeclients.com
SUMMARY:Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity Pathway Analysis
DESCRIPTION:Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the impact of a new drug that has already been through the arduous R&D process for a disease or cancer. Drug repurposing can take this concept and expand on it by looking for other diseases with similar drug target biology. The logic is if they share similar target biology\, they may benefit from the same treatment. \nDuring this training\, we'll cover skills such as:\n• Querying QIAGEN OmicSoft Lands data from sources like TCGA or ICGC and exploring the incidence of a cancer-driving somatic mutation that is targeted by a treatment\n• Creating a cohort of patients within OmicSoft with a disease-causing mutation and wild type for the gene of interest\n• Generating survival curves for each mutant and wild type group for various indications in the relevant OmicSoft Land\n• Using QIAGEN Ingenuity Pathway Analysis (IPA) to generate a mechanism of action network for the drug's target\n• Exploring various network overlay features to enable in silico testing and combination drug partner investigation\n• Searching for publicly available datasets relevant to your chosen indication\n• Comparing the expression profile from our disease state with other publicly available analyses to find other indications or diseases that share similar biology
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/indication-expansion-and-drug-repurposing-using-qiagen-omicsoft-and-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1036_9_QDI_IPAviral_Gi683847570_16x9_Large-1200px_53562.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230803T130000
DTEND;TZID=America/Halifax:20230803T143000
DTSTAMP:20260407T014656
CREATED:20230418T121024Z
LAST-MODIFIED:20241024T182854Z
UID:10000630-1691067600-1691073000@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN IPA
DESCRIPTION:Join us for a 90-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to:\n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \nFor those with IPA license\,\nTo install IPA before or after this training\, please use below installer.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_5526_IPAphosphoproteomicsData_Large-1200px_37427-1-1140x793-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230726T130000
DTEND;TZID=UTC:20230726T143000
DTSTAMP:20260407T014656
CREATED:20230614T133100Z
LAST-MODIFIED:20241024T182916Z
UID:10000651-1690376400-1690381800@staging.digitalinsights.supremeclients.com
SUMMARY:Metagenomics taxonomic profiling using QIAGEN CLC Genomics Workbench
DESCRIPTION:QIAGEN CLC Microbial Genomics Module provides tools and workflows for many various bioinformatics applications\, including microbiome analysis\, isolate characterization\, functional metagenomics and antimicrobial resistance characterization. The module supports the analysis of bacterial\, viral and eukaryotic (fungal) genomes and metagenomes. \nThis training focuses on amplicon-based taxonomic profiling (16S/18S/ITS sequencing OTU clustering). Specifically\, we’ll cover together: \n• An overview of the different tools within QIAGEN CLC Microbial Genomics Module and the research areas supported \n• Taxonomic profiling \n• Importing data \n• Utilization of metadata \n• Downloading and managing references \n• The OTU clustering workflow (analytical pipeline) \n• Downstream processing of abundance tables \n• Creating and exporting high-quality graphics
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/metagenomics-taxonomic-profiling-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230725T130000
DTEND;TZID=UTC:20230725T143000
DTSTAMP:20260407T014656
CREATED:20230614T132014Z
LAST-MODIFIED:20241024T182916Z
UID:10000650-1690290000-1690295400@staging.digitalinsights.supremeclients.com
SUMMARY:Delving into public single-cell RNA-seq data using QIAGEN OmicSoft and Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Single-cell RNA-sequencing (scRNA-seq) is widely used to study tissue heterogeneity\, identify novel cell types\, study pathogenic mechanisms\, develop targeted therapies (including immunotherapy) and more. Accordingly\, scientists have deposited a tremendous amount of scRNA-seq data into public domains like GEO. \nIn this training\, you will learn how to: \n· Locate public single-cell studies of interest to you using QIAGEN Omicsoft Single Cell Lands \n· Study different cell types by dimension reduction plots (for example\, t-SNE\, UMAP) \n· Investigate expression of genes of interest across different cell types (Violin plots\, overlay expression on cluster) \n· Identify key pathways and regulators from scRNA-seq data using QIAGEN IPA
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/delving-into-public-single-cell-rna-seq-data-using-qiagen-omicsoft-and-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230718T130000
DTEND;TZID=UTC:20230718T143000
DTSTAMP:20260407T014656
CREATED:20230614T131211Z
LAST-MODIFIED:20241024T182915Z
UID:10000649-1689685200-1689690600@staging.digitalinsights.supremeclients.com
SUMMARY:Investigating genomic variants using QIAGEN CLC Genomics Workbench\, QCI Interpret-Translational (QCII-T)\, and QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Discovering new genes implicated in hereditary diseases or cancer progression is challenging yet advancing rapidly due to the increase in next-generation sequencing (NGS) cohort data. These data analyses produce insights into associations between gene variants and diseases and the biological mechanisms of these gene variants. \nBy combining QIAGEN CLC Genomics Workbench\, QCII-T and QIAGEN IPA\, you can analyze sequencing data obtained from a variety of NGS technologies\, annotate gene variants using the world’s most comprehensive and up-to-date curated scientific evidence and find biological connections in gene variants with manually curated scientific findings. Using a streamlined NGS analysis workflow\, you’ll get valuable and reliable insights for your research project and speed up your discoveries. \nIn this training\, you’ll:\n1. Learn to import whole genome or exosome sequencing data into QIAGEN CLC Genomics Workbench and use the ultra-fast LightSpeed Module that delivers an end-to-end NGS FASTQ to VCF pipeline\n2. Explore the capabilities in QCII-T which can help accelerate your discoveries from hereditary or tumor cohort analyses to find associations between gene variants and diseases\n3. Learn how to use QIAGEN IPA and its manually curated content\, among other integrated scientific evidence\, to uncover novel biological mechanisms underlying these gene variants
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/investigating-genomic-variants-using-qiagen-clc-genomics-workbench-qci-interpret-translational-qcii-t-and-qiagen-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230713T130000
DTEND;TZID=UTC:20230713T143000
DTSTAMP:20260407T014656
CREATED:20230614T130505Z
LAST-MODIFIED:20241024T182913Z
UID:10000648-1689253200-1689258600@staging.digitalinsights.supremeclients.com
SUMMARY:Target exploration and cell line selection for drug discovery
DESCRIPTION:Cancer cell line models have been a cornerstone of cancer research for decades. Profiling cancer cell lines is a powerful tool to identify gene alterations or cancer-related pathways and to discover potential drug targets. This training will focus on using QIAGEN OmicSoft Lands and Ingenuity Pathway Analysis (IPA) as guides to select cell lines and translate insights gained from cell lines into discovering new possible drug targets. \nIn this 90-minute training\, we’ll explore how you can use our platforms to:\n• Select appropriate cancer cell lines for a variety of applications such as drug discovery\, precision disease modeling\, understanding gene function in cancer and immune-oncology research\n• Examine genes of interest across various ‘omics datasets to analyze changes in expression\, mutation\, hotspots and gene dependency data\n• Generate networks for hypotheses and test them in-silico to improve the translation of insights derived from cell line models to drug target identification\n• Analyze integrated public 'omics data and drug response phenotypes using cell line model systems by exploring data from the Library of Integrated Network-Based Cellular Signatures (LINCS)\n• Prioritize drug targets and profile phenotypic/downstream effects of drug action by overlaying public data on your own generated networks \nOur system uses millions of curated literature findings in the QIAGEN/ IPA Knowledge Base and the OmicSoft digital warehouse. This training is for those of you familiar with QIAGEN IPA\, as well as newcomers interested in learning more.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/target-exploration-and-cell-line-selection-for-drug-discovery/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230711T130000
DTEND;TZID=UTC:20230711T143000
DTSTAMP:20260407T014656
CREATED:20230614T130043Z
LAST-MODIFIED:20241024T182911Z
UID:10000647-1689080400-1689085800@staging.digitalinsights.supremeclients.com
SUMMARY:Pathogen detection and variant analysis using hybrid capture technology and QIAGEN CLC Genomics Workbench
DESCRIPTION:The detection and surveillance of pathogens such as respiratory viruses\, sexually transmitted pathogens\, adventitious agents and antimicrobial-resistant bacteria are increasingly important in healthcare settings and environmental monitoring. The COVID-19 pandemic highlighted the importance of identifying and differentiating variants of concern. By applying the lessons learned from the COVID-19 pandemic to other pathogens of interest\, it’s clear there’s a widespread need for the ability to target sensitive variants using next-generation sequencing (NGS) enrichment strategies and to analyze NGS data. \nIn this training\, we'll use QIAGEN CLC Genomics Workbench to analyze NGS data generated from hybrid capture technology. Using data generated from QIAGEN HYB panels\, you'll learn how to import\, analyze and interpret NGS data. Specifically\, you’ll discover:\n1. How to import NGS data into QIAGEN CLC Genomics Workbench\n2. How to analyze the data using template workflows;\n3. How to interpret the results using the interactive graphics produced by the workflows;\n4. How to modify the template workflows to accommodate custom panels
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/pathogen-detection-and-variant-analysis-using-hybrid-capture-technology-and-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230711T110000
DTEND;TZID=UTC:20230711T123000
DTSTAMP:20260407T014656
CREATED:20230619T140741Z
LAST-MODIFIED:20241024T182917Z
UID:10000652-1689073200-1689078600@staging.digitalinsights.supremeclients.com
SUMMARY:Insights into cancer genomics via COSMIC v98
DESCRIPTION:Our understanding of cancer mechanisms\, genetics and complexities continues to expand rapidly. Without a streamlined\, standardized and easy to understand organizational system to keep track of this plethora of knowledge\, potentially crucial data can effectively be lost. Trusted by scientists for nearly 20 years\, COSMIC is the world’s largest\, most comprehensive\, expert-curated resource for exploring the impact of somatic mutations in human cancers.\n\nJoin Leonie Hodges\, Scientific Communications Officer for COSMIC\, for this webinar to take a journey through COSMIC’s mission\, the results of our latest curation focus and how we have developed our download files to improve accessibility and useability.\n\nThrough the lens of COSMIC v98\, participants of this session will:\n\nDelve into our manual curation and rigorous data annotation processes\, and how the resulting gold standard data enables users to experiment and innovate with confidence.\nGain insight into the motivations behind our curation focuses and the results of our latest focus: rare skin tumors\, including new tumor types/histologies\, a newly fully curated cancer gene and more.\nExplore the revamped COSMIC download files\, with particular focus on their interoperability\, accessibility and useability.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/insights-into-cancer-genomics-via-cosmic-v98/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/QPRO-4267_WEBINAR_QCI_Labroots_COSMIC_A_1x1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230627T130000
DTEND;TZID=UTC:20230627T143000
DTSTAMP:20260407T014656
CREATED:20230516T155417Z
LAST-MODIFIED:20241024T182900Z
UID:10000642-1687870800-1687876200@staging.digitalinsights.supremeclients.com
SUMMARY:De novo assembly\, BLAST and genome finishing using QIAGEN CLC Genomics Workbench
DESCRIPTION:This webinar will introduce users to the tools available for short reads (Illumina) as well as long reads (Oxford Nanopore\, Pac Bio) de novo assembly in QIAGEN CLC Genomics Workbench. It will also go over other useful functionalities such as BLAST and genome finishing. \nParticipants will learn the following: \no Download and install needed plugins.\no Import data required for the analysis.\no Run the de novo assembly workflow.\no For long reads\, improve a de novo assembly by polishing with short\, high-quality reads.\no Map reads to a reference and visualize an assembly.\no For long reads\, correct raw long reads for further analysis.\no Use BLAST to investigate the contigs.\no Analyze and assemble contigs through Genome Finishing tools.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/de-novo-assembly-blast-and-genome-finishing-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230622T110000
DTEND;TZID=UTC:20230622T123000
DTSTAMP:20260407T014656
CREATED:20230516T164935Z
LAST-MODIFIED:20241024T182901Z
UID:10000644-1687431600-1687437000@staging.digitalinsights.supremeclients.com
SUMMARY:Scale your comprehensive genomic profiling workflow with superior automated variant interpretation
DESCRIPTION:Automating and scaling a comprehensive genomic profiling workflow can be a tedious and challenging process that requires lots of time and resources. However\, an intelligent clinical decision support platform and on-demand expert support services can make all the difference.  \nIn this webinar\, learn about QIAGEN Clinical Insight (QCI) Interpret for Oncology\, a clinical decision support platform that has been trusted to analyze and interpret more than 3 million patient molecular profiles worldwide. Unlike other commercial solutions\, QCI Interpret for Oncology is powered by augmented molecular intelligence and offers in-software access to a team of variant scientists to assist you with rare or novel variant research\, curation\, and interpretation. The platform connects to the QIAGEN Knowledge Base—the highest quality genomic knowledge base in the industry—and dynamically computes variant classifications according to AMP/ASCO/CAP and ACMG/AMP guidelines. To help you further scale and reduce hands-on time\, QCI Interpret for Oncology provides over 410\,000 variant interpretation summaries that have all been reviewed by oncologists. This enables you to quickly build custom reports for your oncologists and their patients with the latest diagnostic and prognostic information\, as well as biomarker-directed therapy and clinical trial recommendations. \nBy attending this webinar\, you will: \nReceive a step-by-step guide of how to go from VCF to final report using QCI Interpret for Oncology\nLearn about the platform’s automated variant classification process\nLearn how QIAGEN uses augmented molecular intelligence to enhance our expert curation process\nSee first-hand how to build a custom report with an opportunity to submit your own VCF file for a sample report
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/scale-your-comprehensive-genomic-profiling-workflow-with-superior-automated-variant-interpretation/
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230620T130000
DTEND;TZID=UTC:20230620T143000
DTSTAMP:20260407T014656
CREATED:20230516T154328Z
LAST-MODIFIED:20241024T182900Z
UID:10000641-1687266000-1687271400@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN IPA Deeper Dive: Making most out of user’s core analysis and new features
DESCRIPTION:Many of you who use QIAGEN Ingenuity Pathway Analysis (IPA) have requested a deeper dive into the IPA core analysis (also known as expression analysis - performed on RNA-seq\, scRNA-seq\, proteomics and many other ‘omics data). You’ve specifically requested to cover topics like causal networks\, regulator effects\, etc.\, in more detail. \nThat’s why we’ve designed this training to focus on thesetopics and more: \n· What are the different result types produced by an IPA core analysis? \n· What are the differences between causal network vs. mechanistic network vs. regulator effects? \n· How do you predict molecular activity in IPA? What is a Z-score? \n· What is the new bubble plot feature? \n· How can I edit\, expand and modify the network the way I want it? For example\, add a disease or gene(s) of interest\, remove certain connections\, etc?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ipa-deeper-dive-making-most-out-of-users-core-analysis-and-new-features/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230620T100000
DTEND;TZID=Europe/Paris:20230620T113000
DTSTAMP:20260407T014656
CREATED:20230516T164243Z
LAST-MODIFIED:20241024T182901Z
UID:10000643-1687255200-1687260600@staging.digitalinsights.supremeclients.com
SUMMARY:Interpretieren Sie somatische Varianten einfach und schnell mit HSMD
DESCRIPTION:Verpassen Sie nicht die Gelegenheit\, das bestgehütete Geheimnis von somatischen NGS-Tests kennenzulernen.\nDie von QIAGEN entwickelte neue Datenbank namens HSMD enthält über 2 Jahrzehnte von Experten kuratierte Inhalte aus der QIAGEN Knowledge Base und Daten aus über 300.000 realen Onkologie-Fällen\, um tiefgreifende Einblicke in die genaue Funktion und Handlungsfähigkeit von kleinen Varianten wie SNVs\, Indels und Frameshifts zu bieten\, die "klinisch beobachtet" oder aus wissenschaftlichen Publikationen kuratiert wurden.\nAm 20. Juni werden unsere Experten Ihnen in einer Demonstation die neue Datenbank vorstellen und Ihnen ihre Funktionen\, Fähigkeiten und Anwendungen vorstellen.\nIn diesem Webinar werden Sie lernen:\n• Woher HSMD seine Daten zieht\n• Wie Sie HSMD für verschiedene Anwendungen wie Forschung\, molekulare Tests und pharmazeutische Entwicklung nutzen und anwenden können\n• Wie Sie eine kostenlose\, 5-tägige Testversion von HSMD für Ihr Labor erhalten können
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/interpretieren-sie-somatische-varianten-einfach-und-schnell-mit-hsmd/
LOCATION:Virtual - Germany\, Germany
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230615T130000
DTEND;TZID=UTC:20230615T143000
DTSTAMP:20260407T014656
CREATED:20230315T133249Z
LAST-MODIFIED:20241024T182845Z
UID:10000616-1686834000-1686839400@staging.digitalinsights.supremeclients.com
SUMMARY:RNA-seq data analysis and interpretation using QIAGEN CLC and QIAGEN IPA
DESCRIPTION:This 90-minute training will teach you how to easily analyze and interpret RNA-seq data using QIAGEN CLC Genomics Workbench software and QIAGEN Ingenuity Pathway Analysis (IPA). \nFor RNA-seq data\, you will learn how to:\n• Import FASTQ files\, cell matrix files and metadata and how to download references\n• Map reads to a reference genome and generate gene and transcript counts and QC reports displaying % mapped reads\, knee plots\, etc.\n• Generate visualizations of results\, such as heatmaps\, differential expression tables\, PCA/PCOA plots\, Venn diagrams and others\n• Easily customize RNA-seq workflows\n• Export publication-quality graphics\, tables and reports\n• Send differential expression tables to QIAGEN Ingenuity Pathway Analysis directly from QIAGEN CLC Genomics Workbench to analyze and interpret relevant pathways \nExplore the types of analyses and visualizations you’ll learn to generate (slides from previous training): https://qiagen.showpad.com/share/qiZLmCUS32GZNM1B4llMf
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/rna-seq-data-analysis-and-interpretation-using-qiagen-clc-and-qiagen-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230613T130000
DTEND;TZID=UTC:20230613T143000
DTSTAMP:20260407T014656
CREATED:20230418T130426Z
LAST-MODIFIED:20241024T182857Z
UID:10000636-1686661200-1686666600@staging.digitalinsights.supremeclients.com
SUMMARY:Investigation of inflammatory conditions public data for biomarker and drug target discovery using QIAGEN OmicSoft and IPA
DESCRIPTION:In this 90-minute training on QIAGEN OmicSoft and Ingenuity Pathway Analysis (IPA)\, we’ll cover how to easily query inflammatory conditions related to public data (GEO\, SRA and more) to:\n• Rapidly query and identify public datasets that fit our search criteria\n• Discover and validate biomarker expression in disease tissue\, different treatments and response groups\n• Identify a list of biomarkers specific to a condition (non-responders\, disease-specific\, cell-type specific and more)\n• Confirm condition-specific biomarkers through gene expression heatmaps\n• Investigate biological mechanisms through network study \nAdditional QIAGEN Digital Insights scientists will be on the call to answer your questions and help with other inquiries\, such as how to install the software\, etc.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/investigation-of-inflammatory-conditions-public-data-for-biomarker-and-drug-target-discovery-using-qiagen-omicsoft-and-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230610
DTEND;VALUE=DATE:20230614
DTSTAMP:20260407T014656
CREATED:20230525T162924Z
LAST-MODIFIED:20241024T182903Z
UID:10000646-1686355200-1686700799@staging.digitalinsights.supremeclients.com
SUMMARY:ESHG 2023
DESCRIPTION:Learn about our Sample to Insight solutions for inherited disorders\n\n\n\n\n\nThis year at the European Society for Human Genetics (ESHG) 2023 Annual Meeting\, QIAGEN will be at booth #472 premiering our new barrier-breaking Sample to Insight workflow for inherited disease NGS testing—a fast\, cheap\, ultra-precise panel to report pipeline. \nLearn more about our products and solutions and receive complimentary demos of our bioinformatic software and databases. Our experts will be available to chat with you and answer any questions you may have. We look forward to seeing you at ESHG 2023.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/eshg-2023/
LOCATION:Glasgow\, Glasgow\, Scotland\, United Kingdom
CATEGORIES:Clinical,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1305_1_QDI_QCI_Glasgow_GI519375418.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230608T130000
DTEND;TZID=UTC:20230608T143000
DTSTAMP:20260407T014656
CREATED:20230418T131657Z
LAST-MODIFIED:20241024T182859Z
UID:10000637-1686229200-1686234600@staging.digitalinsights.supremeclients.com
SUMMARY:Antimicrobial resistance (AMR) and multi-locus sequence typing (MLST) using QIAGEN CLC Genomics Workbench
DESCRIPTION:You asked for it by popular demand\, and we’re here to deliver. In this training\, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated with other functionalities such as multi-locus sequence typing (MLST).\nIn this training\, we’ll cover:\n• Introduction to AMR\, MLST and relevant databases\n• QIAGEN Microbial Insight - Antimicrobial Resistance database (QMI-AR)\n• Importing data and downloading needed databases\n• Finding resistance with nucleotide DB\, PointFinder and ShortBRED\n• Integrating AMR with MLST\n• Exporting high-resolution graphics and result tables
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/antimicrobial-resistance-amr-and-multi-locus-sequence-typing-mlst-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230608T110000
DTEND;TZID=UTC:20230608T120000
DTSTAMP:20260407T014656
CREATED:20230525T145821Z
LAST-MODIFIED:20241024T182901Z
UID:10000645-1686222000-1686225600@staging.digitalinsights.supremeclients.com
SUMMARY:Sample to Insight at LightSpeed: A barrier-breaking workflow for inherited disease NGS testing
DESCRIPTION:Get a first-hand look at QIAGEN’s new Sample to Insight Hereditary solution. By attending this webinar\, you will: \n\nLearn more about each workflow component.\nHear from experts in the field as they discuss how this technology advances the diagnosis and management of inherited diseases.\nExamine real-world case studies demonstrating the clinical utility and cost-effectiveness of the solution.\n\nIf your lab needs a fast\, cost-effective\, ultra-precise workflow for germline NGS testing\, you do not want to miss this webinar.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/sample-to-insight-at-lightspeed-a-barrier-breaking-workflow-for-inherited-disease-ngs-testing/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230607T110000
DTEND;TZID=UTC:20230607T123000
DTSTAMP:20260407T014656
CREATED:20230511T112735Z
LAST-MODIFIED:20241024T182900Z
UID:10000640-1686135600-1686141000@staging.digitalinsights.supremeclients.com
SUMMARY:Unlocking the power of API-based 'omics queries
DESCRIPTION:If you're a data scientist or bioinformatician working in biopharma\, here's your chance to explore an advanced and comprehensive way to access and analyze high-quality 'omics data. The QIAGEN OmicSoft API provides a powerful and flexible platform for easy data discovery\, retrieval\, filtering\, analysis and visualization. In this webinar\, you'll learn how to leverage the OmicSoft API to access vast amounts of multi-omics data and perform custom analyses. We will also highlight the capabilities of the OmicSoft API to query across data sources to obtain a complete picture of the available 'omics data for any given disease. \nJoin us to learn how OmicSoft API can revolutionize your data analysis workflows and help you make more informed decisions for your drug and target discovery projects. \nIn this webinar\, we'll discuss how to: \n\nAvoid the pitfalls of poorly labeled data\nUse the OmicSoft API to accelerate queries and promote consistency\nPerform multi' omics data analysis to reveal patterns and prioritize hypotheses\nLeverage curated metadata\, including sample clinical data\, to structure queries\nDrive efficiency in your drug discovery and bioinformatics programs\n\nDon't miss this chance to learn how to unlock the power of API-based 'omics queries.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/unlocking-the-power-of-api-based-omics-queries-jun-7/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/faefb219-97c3-467a-b5aa-4c5f12517be6.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230606
DTEND;VALUE=DATE:20230609
DTSTAMP:20260407T014656
CREATED:20230504T134649Z
LAST-MODIFIED:20241024T182859Z
UID:10000639-1686009600-1686268799@staging.digitalinsights.supremeclients.com
SUMMARY:Roman Testing Conference
DESCRIPTION:In 2023\, we want to hear stories of improved communication and bridging gaps. Of technology used to harness the power of agility. Of process improvements\, impediments removal and common goals. About changing attitudes\, ways of working and minds. We want to hear stories of failure or win\, standing up against change or championing it. What you changed. What you learned from it. \nWe are looking to build a program offering a wide variety of inspiring talks and hands-on workshops. The conference will span over 3 days with the first two days consisting of one- and two-day workshops and training. On the third day we will have a classic multi-track setup with a variety of keynotes and talks. We will also be trying out a few exciting concepts that we will share more information about along the way.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/roman-testing-conference-jun-6-8/
LOCATION:Romania\, Cluj-Napoca\, Romania
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230525T130000
DTEND;TZID=UTC:20230525T143000
DTSTAMP:20260407T014656
CREATED:20230503T054433Z
LAST-MODIFIED:20241024T182859Z
UID:10000638-1685019600-1685025000@staging.digitalinsights.supremeclients.com
SUMMARY:Acceda rápidamente a amplios conocimientos para interpretar variantes somáticas con la HSMD
DESCRIPTION:Dentro de las aplicaciones oncológicas\, la capacidad de identificar alteraciones genéticas potencialmente accionables y explorar las vulnerabilidades moleculares del cáncer es cada vez más difícil. \n\nUna nueva base de datos desarrollada por QIAGEN\, la HSMD\, contiene más de 2 décadas de contenido curado por expertos y datos de la QIAGEN Knowledge Base con más de 300.000 casos de oncología del mundo real para proporcionar una comprensión profunda y precisa de la accionabilidad de pequeñas variantes\, como SNVs\, indels y frameshifts\, que han sido "clínicamente observadas" o consideradas por la literatura científica. \n\nEl 25 de mayo\, únase a nuestros expertos en un tour virtual a la nueva base de datos y una presentación de sus características\, capacidades y aplicaciones.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/acceda-rapidamente-a-amplios-conocimientos-para-interpretar-variantes-somaticas-con-la-hsmd-may-25/
LOCATION:Virtual - Argentina\, Argentina
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230523T130000
DTEND;TZID=UTC:20230523T143000
DTSTAMP:20260407T014656
CREATED:20230418T125027Z
LAST-MODIFIED:20241024T182856Z
UID:10000635-1684846800-1684852200@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deeper dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:In this 90-minute training session\, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways\, diseases\, biological functions\, tissues and cell types. \nWe’ll cover topics such as:\n- How to analyze miRNA-seq datasets alone\, or both miRNA and corresponding mRNA datasets together\n- How to use QIAGEN IPA without a dataset\, using miRNA IDs\n- Introduction to databases and curated content specific to miRNA\n- How to effectively apply various filters and functionalities to identify biomarkers\, key targets and novel biological mechanisms
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deeper-dive-mirna-investigation-using-qiagen-ingenuity-pathway-analysis-ipa-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230518T100000
DTEND;TZID=UTC:20230518T120000
DTSTAMP:20260407T014656
CREATED:20230329T122532Z
LAST-MODIFIED:20241024T182851Z
UID:10000626-1684404000-1684411200@staging.digitalinsights.supremeclients.com
SUMMARY:How to improve your existing pipeline for somatic mutation analysis\, interpretation and reporting: Part 2
DESCRIPTION:We are excited to bring thought leaders\, NGS experts\, lab directors\, variant scientists\, clinicians\, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18\, 2023. \nThe two-part\, content-rich event will feature invited lectures from lab directors and clinical geneticists\, thought-provoking discussions on the future of comprehensive genomic profiling\, and educational presentations on the latest databases\, software\, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis\, interpretation and reporting\, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time\, improve operational costs\, and scale for higher throughput. \nMeet the speakers and view the full agenda here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-improve-your-existing-pipeline-for-somatic-mutation-analysis-interpretation-and-reporting-part-2/
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230516T130000
DTEND;TZID=UTC:20230516T143000
DTSTAMP:20260407T014656
CREATED:20230418T124321Z
LAST-MODIFIED:20241024T182856Z
UID:10000634-1684242000-1684247400@staging.digitalinsights.supremeclients.com
SUMMARY:Pathway and network analysis on different types of lists with QIAGEN IPA
DESCRIPTION:You may not have a typical transcriptomics dataset (i.e.\, a list of genes with differential expression)\, yet\, you’d like to analyze a list of IDs. In this training\, we will explore how to perform pathway and network analysis for lists of IDs in QIAGEN IPA.\nExamples of lists that we’ll explore include:\n• A gene/protein/metabolite list coming from a paper\, generated in a lab or from a collaborator without differential expression\n• A list of RS IDs for variants with or without numerical values such as p-values\n• A list of proteins with Z-score (or other numerical value) calculated outside of IPA\n• Other lists where you have mainly IDs and but no differential expression data \nIn this IPA training\, you’ll learn how to:\n• Upload and perform a pathway analysis (also known as core analysis) on a list of genes\, proteins\, metabolites or other types of IDs\n• Open and investigate pathways and networks for understanding biological mechanisms\n• Compare between analyses to identify similarities and differences for applications such as biomarker discovery\n• Generate a custom network and contextualize it using public data
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/pathway-and-network-analysis-on-different-types-of-lists-with-qiagen-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230516T100000
DTEND;TZID=UTC:20230516T113000
DTSTAMP:20260407T014656
CREATED:20230418T123846Z
LAST-MODIFIED:20241024T182856Z
UID:10000633-1684231200-1684236600@staging.digitalinsights.supremeclients.com
SUMMARY:How to improve your existing pipeline for somatic mutation analysis\, interpretation and reporting: Part 2
DESCRIPTION:We are excited to bring thought leaders\, NGS experts\, lab directors\, variant scientists\, clinicians\, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18\, 2023. \nThe two-part\, content-rich event will feature invited lectures from lab directors and clinical geneticists\, thought-provoking discussions on the future of comprehensive genomic profiling\, and educational presentations on the latest databases\, software\, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis\, interpretation and reporting\, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time\, improve operational costs\, and scale for higher throughput. \nMeet the speakers and view the full agenda here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-improve-your-existing-pipeline-for-somatic-mutation-analysis-interpretation-and-reporting-part-2-2/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230511T130000
DTEND;TZID=UTC:20230511T143000
DTSTAMP:20260407T014656
CREATED:20230418T123154Z
LAST-MODIFIED:20241024T182855Z
UID:10000632-1683810000-1683815400@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitors in the context of biomarkers\, drug targets and pathways
DESCRIPTION:In this training\, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers\, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO\, SRA\, TCGA and more. \nIn this training\, you’ll learn how to: \n· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases \n· Derive a biomarker/gene signature from a specific condition (for example\, non-responders of a drug\, or a particular disease/disease subtype and others) \n· Correlate expression of multiple genes and biomarkers \n· Compare different experimental groups (e.g.\, your own data and/or public data) at both the levels of gene expression and pathways/regulatory networks activity
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitors-in-the-context-of-biomarkers-drug-targets-and-pathways/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230509T130000
DTEND;TZID=UTC:20230509T143000
DTSTAMP:20260407T014656
CREATED:20230411T170801Z
LAST-MODIFIED:20241024T182854Z
UID:10000629-1683637200-1683642600@staging.digitalinsights.supremeclients.com
SUMMARY:Whole genome sequencing (WGS)\, rapid WGS and ultra-rapid WGS for hereditary disorders – where speed matters
DESCRIPTION:QIAGEN CLC LightSpeed Module delivers an ultra-fast\, end-to-end hereditary NGS FASTQ to VCF pipeline. LightSpeed takes raw FASTQ files generated by paired-end 150 bp sequencing protocols and performs quality trimming\, adapter trimming\, read mapping\, deduplication\, local realignment\, QC and germline variant calling. \nMore details: https://qiagen.showpad.com/share/Tue4ZxKsjAFetyoswbTfE \nCloud module: QIAGEN CLC Genomics Cloud computing software allows you to launch analyses from CLC Workbenches or CLC Servers for execution on AWS.\nhttps://qiagen.showpad.com/share/ct2e3M9LfLazzuMMchqhG\n• Overview of Genomics workbench and Platform\n• Server / Cloud module overview\n• Breaking the speed of light\n• LightSpeed is arguably the fastest and cheapest-to-run hereditary FASTQ-to-VCF WGS pipeline available\n• Benchmarks / comparisons\n• Demo of lightspeed and cloud module for Fastq to vcf\n• Install plugin\n• Download reference(s)\n• Execute workflow and review results
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/whole-genome-sequencing-wgs-rapid-wgs-and-ultra-rapid-wgs-for-hereditary-disorders-where-speed-matters-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230504T130000
DTEND;TZID=UTC:20230504T143000
DTSTAMP:20260407T014656
CREATED:20230418T122646Z
LAST-MODIFIED:20241024T182855Z
UID:10000631-1683205200-1683210600@staging.digitalinsights.supremeclients.com
SUMMARY:Single-cell RNA-seq data analysis and interpretation
DESCRIPTION:Explore how to analyze and interpret your own single-cell RNA-seq (scRNA-seq) data using QIAGEN CLC Genomics Workbench and QIAGEN Ingenuity Pathway Analysis (IPA). \nIn this 90-minute training\, you’ll learn how to:\n• Start with FASTQ\, cell matrix file and/or differential expression file for scRNA-seq data\n• Either automate or customize your analysis pipeline/workflow\, depending on your needs\n• Easily generate visualizations such as t-SNE\, UMAP\, heatmap\, differential expression table\, dot plots and more\n• Upload differential expression data to QIAGEN IPA (either from QIAGEN CLC or from another source)\n• Perform pathway analysis on scRNA-seq data and compare different clusters to discover novel biological mechanisms\, cell type-specific biomarkers and key regulators/targets\n• Export results in the form of high-quality images or tabular format \nSlides from a previous similar training: https://qiagen.showpad.com/share/WAXz1vrHBsvArdeceWpcX
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/single-cell-rna-seq-data-analysis-and-interpretation/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230504T110000
DTEND;TZID=UTC:20230504T120000
DTSTAMP:20260407T014656
CREATED:20230329T123527Z
LAST-MODIFIED:20241024T182853Z
UID:10000628-1683198000-1683201600@staging.digitalinsights.supremeclients.com
SUMMARY:Como anotar variantes somáticas e avaliar a prevalência delas com um único banco de dados
DESCRIPTION:Dentro das aplicações oncológicas\, a habilidade de identificar alterações genéticas potencialmente acionáveis e explorar as vulnerabilidades moleculares do câncer está se tornando cada vez mais difícil. \nUm novo banco de dados desenvolvido pela QIAGEN\, o HSMD\, contém mais de 2 décadas de conteúdo com curadoria especializada e dados da QIAGEN Knowledge Base com mais de 300.000 casos oncológicos de mundo real para fornecer um entendimento profundo e preciso da acionabilidade de variantes pequenas\, tais como SNVs\, indels e frameshifts\, que têm sido “observadas clinicamente” ou consideradas pela literatura científica. \nNo dia 4 de maio\, junte-se a nossos especialistas para um tour virtual do novo banco de dados e apresentação dos seus recursos\, capacidades e aplicações.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/como-anotar-variantes-somaticas-e-avaliar-a-prevalencia-delas-com-um-unico-banco-de-dados/
LOCATION:Virtual - Portugal\, Portugal
CATEGORIES:Clinical,Webinar
END:VEVENT
END:VCALENDAR